WallStSmart
BIVI

Biovie Inc

NASDAQ: BIVI · HEALTHCARE · BIOTECHNOLOGY

$1.65
+4.43% today

Updated 2026-04-30

Market cap
$11.31M
P/E ratio
P/S ratio
EPS (TTM)
$-3.28
Dividend yield
52W range
$1 – $13
Volume
0.1M

Biovie Inc (BIVI) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2013201420152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$0.00$0.00$51036.00$229377.00$229377.00$229377.00$229377.00$229377.00$237421.00$266842.00$229377.00$229377.00
Gross profit$0.00$0.00$-51036.00$-229000.00$-229000.00$-229000.00$-229000.00$-229377.00$-237421.00$-266842.00$-229377.00$-229377.00
Gross margin
R&D$49419.00$4196.00$37901.00$466354.00$370853.00$1.01M$1.15M$133.19M$17.26M$33.30M$23.10M$9.27M
SG&A$272966.00$229181.00$343091.00$857883.00$1.77M$1.26M$1.31M$4.64M$9.77M$11.55M$8.85M$8.57M
Operating income$-70060.00$-322385.00$-233377.00$-432028.00$-1.55M$-2.37M$-2.50M$-2.69M$-138.05M$-27.25M$-45.08M$-32.18M$-18.07M
Operating margin
EBITDA$20.00$-321896.00$-233008.00$-380806.00$-1.32M$-2.14M$-2.27M$-2.46M$-137.82M$-27.02M$-45.73M$-31.95M$-16.98M
EBITDA margin
EBIT$-70040.00$-322385.00$-233377.00$-431842.00$-1.55M$-2.37M$-2.50M$-2.69M$-138.05M$-27.25M$-45.96M$-32.18M$-17.21M
Interest expense$489.00$369.00$81.00$222942.00$40960.00$273.00$4.77M$559455.00$2.16M$4.30M$2.89M$332720.00
Income tax$20.00$-489.00$-369.00$-105.00$-223000.00$-1.00$-51400.00$4.77M$559455.00$-3.29M$4.30M$-229377.00
Effective tax rate-0.0%0.2%0.2%0.0%14.4%0.0%2.1%-40.1%-0.4%11.2%-9.4%0.7%0.0%
Net income$-70040.00$-321896.00$-233008.00$-431923.00$-1.33M$-2.41M$-2.44M$-16.68M$-130.25M$-26.08M$-50.26M$-32.12M$-17.54M
Net income growth (YoY)-359.6%+27.6%-85.4%-208.2%-81.3%-1.3%-582.4%-681.0%+80.0%-92.7%+36.1%+45.4%
Profit margin